Qiagen NV, 10% Owner at HTG MOLECULAR DIAGNOSTICS, INC (HTGM), bought 753,012 shares on 2017-10-26, disclosed to the SEC on 2017-11-07.
Open-market purchase of $0 HTGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| EGEI | BUY | 2007-06-06 | $66K | — | Filing → |
| EGEI | BUY | 2007-06-04 | $7K | — | Filing → |
| EGEI | BUY | 2007-05-31 | $52K | — | Filing → |